Two Directors at Greenbrier Companies Inc sold 11,454 shares at between 52.480USD and 52.942USD. The significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...
BOSTON--(BUSINESS WIRE)-- State Street Corporation (NYSE: STT) announced today that its Chairman and Chief Executive Officer, Ron O’Hanley, and Vice Chairman and Chief Financial Officer, Eric Aboaf, will participate in Bernstein’s 40th Annual Strategic Decisions Conference in New York, NY on Friday, May 31, 2024, at 9:00 am ET. An audio webcast of the event will be accessible on the home page of State Street’s Investor Relations website, . A recorded replay will be available on the Investor Relations website later that day, for approximately ninety days following the presentation. About St...
Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology - Publication highlights administration of setmelanotide therapy resulted in a mean percent reduction in BMI of 15% at 16 weeks and 26% at one year of treatment - - Topline data from ongoing pivotal Phase 3 clinical trial in hypothalamic obesity on track for 2Q 2025 - BOSTON, April 29, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on...
BOSTON--(BUSINESS WIRE)-- State Street Corporation (NYSE: STT) today released the results of its third annual private markets survey1, which explores the allocations of 480 institutional investors including traditional asset managers, private market managers, insurance companies, and asset owners across North America, Latin America, Europe, and Asia-Pacific. The survey reveals that the rotation from public to private assets within portfolio allocations will grow further in the coming years. Over a third of institutions (36%) have already allocated more than 50% of their portfolio to private ...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
A director at Caleres Inc sold 36,625 shares at 36.945USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, May 7, 2024 to report its first quarter 2024 financial results and provide a corporate update. To access the live conference call, participants may register . Wh...
Vicor Corporation Reports Results for the First Quarter Ended March 31, 2024 ANDOVER, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ: VICR) today reported financial results for the first quarter ended March 31, 2024. These results will be discussed later today at 5:00 p.m. Eastern Time, during management’s quarterly investor conference call. The details for the call are below. Revenues for the first quarter ended March 31, 2024 totaled $83.9 million, a 14.3% decrease from $97.8 million for the corresponding period a year ago, and a 9.5% sequential decrease from $92.7...
ARLINGTON, Va.--(BUSINESS WIRE)-- AeroVironment (AV) has introduced its Autonomy Retrofit Kit (ARK) and AVACORE software demonstrating the company’s commitment to advancing autonomy and machine learning capabilities to increase effectiveness of autonomous systems and reduce operator burdens. ARK and AVACORE bring AV’s accelerated autonomy to fielded assets such as and , in addition to future autonomous systems. This press release features multimedia. View the full release here: AV's ARK and AVACORE bring accelerated autonomy to unmanned aircraft systems such as AV's Puma 3 AE and Puma LE (Ph...
ARLINGTON, Va.--(BUSINESS WIRE)-- AeroVironment (AV) was selected by the U.S. Marine Corps for the first phase of the Organic Precision Fires-Light (OPF-L) program of record. AV’s Switchblade 300 Block 20 loitering munition system (LMS) will provide the Marine Corps with organic, anti-armor/anti-personnel, precision fires capability at the tactical level. AV was awarded an initial order of $8.9M on a contract with a maximum potential value of $249M. This press release features multimedia. View the full release here: AV’s Switchblade 300 Block 20 loitering munition will provide the Marine Corp...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.